Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia.
Clin. Cancer Res., Mar;14(5):1446-54 (2008)
Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemia.
Clin. Cancer Res., May;17(9):2977-86 (2011)
The potential for dasatinib in treating chronic lymphocytic leukemia, acute myeloid leukemia, and myeloproliferative neoplasms.
Leuk. Lymphoma., May;52(5):754-63 (2011)
Treatment of relapsed and refractory acute myeloid leukemia with diaziquone and mitoxantrone: a CALGB phase I study.
Am. J. Hematol., Oct;35(2):80-3 (1990)
A phase II trial of palliative docetaxel plus 5-fluorouracil for squamous-cell cancer of the head and neck.
Ann. Oncol., May;11(5):535-9 (2000)
Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study.
Oral Oncol., Oct;39(7):724-7 (2003)
Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 given as a 1-hour intravenous infusion in patients with advanced solid tumors.
Clin. Cancer Res., Apr;10(7):2222-30 (2004)
Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinoma.
Cancer., Oct;104(7):1418-27 (2005)
ELF4 is fused to ERG in a case of acute myeloid leukemia with a t(X;21)(q25-26;q22).
Leuk. Res., Aug;30(8):1037-42 (2006)
Diffuse cellular and fibrosing interstitial pneumonitis with desquamative interstitial pneumonitis-like features associated with myeloid neoplasia.
Am. J. Surg. Pathol., Oct;33(10):1485-93 (2009)
Genomic alterations in myeloid neoplasms with novel, apparently balanced translocations.
Cancer Genet., Feb;204(2):68-76 (2011)
Outcome of older adults with cytogenetically normal AML (CN-AML) and FLT3 mutations.
Leuk. Res., Dec;35(12):1611-5 (2011)
Granulocyte-colony stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022.
Blood., Feb;89(3):780-8 (1997)
An evaluation of combinations of diaziquone, etoposide and mitoxantrone in the treatment of adults with relapsed or refractory acute myeloid leukemia: results of 8722, a randomized phase II study conducted by Cancer and Leukemia Group B.
Leukemia., Feb;12(2):139-43 (1998)
A phase II study of combined oral uracil and ftorafur with leucovorin for patients with squamous cell carcinoma of the head and neck.
Cancer., Jul;92(2):326-31 (2001)
Hematologic changes in anorexia nervosa.
JAMA., May;241(20):2190-1 (1979)
Phase II trial of m-AMSA therapy in refractory Hodgkin's disease and non-Hodgkin's lymphoma: Cancer and Leukemia Group B Study 7972.
Cancer Treat Rep., Oct;70(10):1233-4 (1986)
Intensive recombinant interleukin-2 and alpha-interferon therapy in patients with advanced head and neck squamous carcinoma.
Cancer., Apr;71(7):2326-31 (1993)